Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants

This study has been terminated.

(Following program review within Pfizer, decision was made not to go ahead with this study. This study is cancelled)

Sponsor:

Information provided by (Responsible Party):

Wyeth is now a wholly owned subsidiary of Pfizer

ClinicalTrials.gov Identifier:

NCT00798304

First received: November 25, 2008

Last updated: February 20, 2013

Last verified: February 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	January 2011
Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	February 20, 2013